Related Experiment Video

Updated: Jun 3, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Response of hairy cell leukemia to bendamustine

Robert J Kreitman, Evgeny Arons, Maryalice Stetler-Stevenson

    Leukemia & Lymphoma
    |April 6, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: Jun 3, 2026

    Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
    08:31

    Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

    Published on: October 17, 2025

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...

    Articles linked to this work by shared authors, journal, and citation graph.

    DNA methylation-based classification of hematolymphoid neoplasms.

    Blood advances·2026

    Updated consensus guidelines for the diagnosis and management of patients with HCL and HCL variant.

    Blood·2026

    Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells.

    Science translational medicine·2026

    Expert consensus opinion on the management of hairy cell leukemia in elderly patients.

    Leukemia & lymphoma·2025

    Phase 2 trial of rituximab with either pentostatin or bendamustine for multiply relapsed or refractory hairy cell leukemia.

    Blood·2025

    COVID-19 vaccination in patients with classic and variant hairy cell leukemia.

    Blood neoplasia·2025

    Evaluation of hypomethylating agents with or without venetoclax in patients with accelerated phase and blast phase myeloproliferative neoplasms: a HERO consortium study.

    Leukemia & lymphoma·2026

    Soluble PD-L1 as prognostic biomarker in acute myeloid leukemia.

    Leukemia & lymphoma·2026

    Dose optimization of single-agent inotuzumab ozogamicin in adults with relapsed/refractory acute lymphoblastic leukemia.

    Leukemia & lymphoma·2026

    Impact of Area Deprivation Index in patients with newly diagnosed acute myeloid leukemia treated with a venetoclax-based regimen: a single-center retrospective study.

    Leukemia & lymphoma·2026

    Palliative care and hospice utilization in patients with relapsed or refractory diffuse large B-cell lymphoma in the era of CART and novel immunotherapies.

    Leukemia & lymphoma·2026

    How to treat hepatic extra-medullary involvement of myeloma: a case report and review of literature.

    Leukemia & lymphoma·2026

    Sedative-hypnotic properties and mitochondrial effects of coenzyme Q2 in mice.

    Current molecular pharmacology·2026

    Trends in Medicines Discontinuation and Implications for Access in Brazil (2014-2024).

    Pharmacoepidemiology and drug safety·2026

    Carabrone alleviates neuroinflammation by covalently targeting ubiquitin conjugating enzyme UBE2D3 in experimental autoimmune encephalomyelitis.

    European journal of pharmacology·2026

    The natural coumarin 7-methoxy-8-isopentenyloxycoumarin alleviates LPS-induced inflammation by suppressing NF-κB and the MAPK/AP-1 pathways and accelerating COX-2 proteasomal degradation.

    European journal of pharmacology·2026

    Emergency department diagnosis and management of acetaminophen or salicylate toxicity.

    Emergency medicine practice·2026

    Reduced Codeine Analgesic Efficacy Associated with Nicardipine in a Patient with Medication-Overuse Headache: A Case Report.

    Journal of pain & palliative care pharmacotherapy·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us